Latest News in the pharma Industry

Biopharma News

Biologics: The Driving Force for CDMOs

Biologics: The Driving Force for CDMOs

22 Mar 2020

CDMOs build capacity to capitalise on biologics boom

Read more 
FDB to triple UK microbial production capacity as Fujifilm commits to $83 million investment

FDB to triple UK microbial production capacity as Fujifilm commits to $83 million investment

19 Mar 2020

Fujifilm Diosynth Biotechnologies will triple microbial production capacity at its UK Teesside facility after joint owner Fujifilm Corporation pledged to invest 9 billion yen (USD83 million) in the biologics focused CDMO.

Read more 
Oxford Biomedica signs LSA with Juno Therapeutics

Oxford Biomedica signs LSA with Juno Therapeutics

19 Mar 2020

Cell and gene focused CDMO Oxford Biomedica (OXB) has signed a licence and clinical supply agreement which could be worth up to USD227 million with Juno Therapeutics, the firms announced Wednesday.

Read more 
What Impact will Coronavirus have on Pharma Supply Chains?

What Impact will Coronavirus have on Pharma Supply Chains?

19 Mar 2020

The worldwide inter-dependency of pharmaceutical manufacturing is highlighted by the ongoing Coronavirus situation. How can the global supply of diagnostic kits, drugs, medical supplies, and equipment be sustained to treat patients in the face of suppl...

Read more 
Vaxxas HD-MAP to deliver vaccines directly to the skin

Vaxxas HD-MAP to deliver vaccines directly to the skin

17 Mar 2020

Company awarded US$5 million grant for clinical study of measles and rubella vaccination using Vaxxas’ high-density, micro-array patch.

Read more 
Artificial Intelligence: Moving beyond efficiency gains in drug development

Artificial Intelligence: Moving beyond efficiency gains in drug development

16 Mar 2020

Is the pharma industry making the most of AI’s potential when it comes to accelerating and enhancing pharmaceutical drug development?

Read more 
Unlocking the potential of cannabinoid-derived drugs

Unlocking the potential of cannabinoid-derived drugs

11 Mar 2020

Following the 2018 FDA approval of GW Pharmaceuticals’ Epidiolex®, there has been increased interest in the development of cannabinoid-derived drug substances for innovative new therapies. We examine the state of the market and future potenti...

Read more 
Sartorius simplifies biologics production with new bioreactor

Sartorius simplifies biologics production with new bioreactor

9 Mar 2020

Company launches BIOSTAT STR Generation 3 bioreactor with BIOBRAIN automation platform.

Read more 
Thermo Fisher Scientific to acquire Qiagen

Thermo Fisher Scientific to acquire Qiagen

3 Mar 2020

Thermo Fisher Scientific said Tuesday it has agreed to buy Dutch molecular testing and diagnostics specialist Qiagen for €39 per share in cash, valuing the overall transaction at around USD 11.5 billion.

Read more 
Potential first-in-class treatment reaches significant milestone

Potential first-in-class treatment reaches significant milestone

2 Mar 2020

The US Food and Drug Administration (FDA) accepts for review Pfizer and Eli Lilly's Biologics License Application (BLA) for tanezumab — a non-opioid treatment for patients with chronic pain due to moderate-to-severe osteoarthritis.

Read more 
Trump and pharma execs to discuss progress on COVID-19 cure

Trump and pharma execs to discuss progress on COVID-19 cure

2 Mar 2020

The White House task force and the US President will meet drug makers this afternoon to discuss "progress on a vaccine and cure".

Read more 
Packaging Toward a Sustainable Future

Packaging Toward a Sustainable Future

2 Mar 2020

With the world’s attitude to tackling climate change arguably the global number one hot topic of 2019, the issue of sustainability is an emerging theme in pharmaceutical packaging.

Read more